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Abstract
Background: Mycobacterium tuberculosis, a causative agent of chronic tuberculosis disease, is widespread among some
animal species too. There is paucity of information on the distribution, prevalence and true disease status of tuberculosis in
Asian elephants (Elephas maximus). The aim of this study was to estimate the sensitivity and specificity of serological tests to
diagnose M. tuberculosis infection in captive elephants in southern India while simultaneously estimating sero-prevalence.
Methodology/Principal Findings: Health assessment of 600 elephants was carried out and their sera screened with a
commercially available rapid serum test. Trunk wash culture of select rapid serum test positive animals yielded no animal
positive for M. tuberculosis isolation. Under Indian field conditions where the true disease status is unknown, we used a
latent class model to estimate the diagnostic characteristics of an existing (rapid serum test) and new (four in-house ELISA)
tests. One hundred and seventy nine sera were randomly selected for screening in the five tests. Diagnostic sensitivities of
the four ELISAs were 91.3–97.6% (95% Credible Interval (CI): 74.8–99.9) and diagnostic specificity were 89.6–98.5% (95% CI:
79.4–99.9) based on the model we assumed. We estimate that 53.6% (95% CI: 44.6–62.8) of the samples tested were free
from infection with M. tuberculosis and 15.9% (97.5% CI: 9.8 - to 24.0) tested positive on all five tests.
Conclusions/Significance: Our results provide evidence for high prevalence of asymptomatic M. tuberculosis infection in
Asian elephants in a captive Indian setting. Further validation of these tests would be important in formulating area-specific
effective surveillance and control measures.
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Introduction
Conservation medicine enables us to rethink the linkages
between human, animal, and environmental health [1], [2]. As
wildlife populations become more fragmented and less genetically
diverse stochastic events leading to disease outbreaks could
become more common. A case in hand is that of the Asian
elephant (Elephas maximus) an ‘‘Endangered’’ flagship species and
featuring on the ‘2010 IUCN Red List of Threatened Species’ [3].
About 39,463-47,427 wild elephants are found in their 13 range
countries in Asia [4]. Estimates of Asian elephant numbers in the
wild in India are 26,000–28,000 of which 14,000 are found in
southern India [5]. About 3467–3667 elephants are also held in
captivity in India (http://envfor.nic.in/pe/PE%20Note.pdf) at
forest camps, temples, zoological gardens and circuses, thus
constituting a substantial population living in close proximity to
humans.
Both humans and elephants are susceptible to infection
primarily with M. tuberculosis. Importantly, TB is a serious zoonotic
disease in elephants [6], [7], [8], [9], [10] and infects about 11-
25% of tested captive elephant populations in USA, India and
Nepal [11]. The transmission, pathobiology and immune corre-
lates of TB are poorly understood in Asian elephants. There is
paucity of information on the time intervals between exposure,
seroconversion, and shedding of the bacilli as also latent versus
active disease status. Equivalent to the culture of human sputum
[12], [13], [14] trunk wash culture for isolation of M. tuberculosis
remains the ‘gold standard’ of ante-mortem TB diagnostics in
elephants [15]. In its absence, ante-mortem TB diagnosis presents
a conundrum [16]. Clinical signs such as chronic weight loss,
weakness, anorexia, exercise intolerance and abnormal discharge
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from the trunk [17] are frequently absent or seen at the terminal
stages. Intradermal tuberculin test [17], [18] and radiographic
thoracic evaluation [17] are unsuccessful in elephants. The
GenProbe Amplified Mycobacterium tuberculosis Direct Test (MTD;
Gen-Probe, San Diego, CA, USA) has found limited use [19],
while ELISA [17], [20], restriction fragment length polymorphism
(RFLP) [6], [17], [18] and serological tests such as the dual path
platform (VetTB test), multi-antigen print immunoassay (MAPIA)
and the rapid serum test (RT, ElephantTB STAT-PAK) from
Chembio Diagnostics (Medford, USA) have also been evaluated in
elephants [21], [22], [23].
In this study, we report screening of elephants with RT and four
in-house ELISAs using M. tuberculosis H37Rv antigens EsxA-6 kDa
early secretory antigenic target (ESAT-6) (Rv3875); EsxB-10 kDa
culture filtrate antigen (CFP10) (Rv3874); PE_PGRS17 (Rv0978c)
and PE_PGRS11 (Rv0754). The ESAT-6 and CFP10 proteins
function in inducing interferon gamma (IFNc) from memory
effector cells upon infection with pathogenic mycobacteria [24],
[25]. The proline glutamic acid (PE) and proline-proline-glutamic
acid (PPE) families of acidic, glycine-rich proteins are unique to
the Mycobacteria [26] and many function as cell surface antigens.
The PE_PGRS11 (Rv0754) is a hypoxia responsive gene that
encodes a functional phosphoglycerate mutase [27] and
PE_PGRS17 and PE_PGRS11 antigens induce maturation and
activation of human dendritic cells [28].
Performance characteristics of a diagnostic test should ideally
enable us to distinguish between infected and non-infected
animals. Notably, estimation of DSe (the proportion of infected
animals correctly identified by the diagnostic test) and DSp (the
proportion of non-infected animals accurately identified by the
diagnostic test) of any index test is generally derived by comparing
it to a standardized and validated ‘gold standard’ with the assumed
sensitivity and specificity of 100% [29], [30], [31]. However, the
gold standard could suffer from serious deficiencies. For example,
the ante-mortem trunk wash culture for M. tuberculosis/M. bovis in
Asian elephants is reported to suffer from poor sensitivity [17],
[22], logistical issues in sample collection and processing and slow
turnaround time. In view of these observations, we have utilized
Latent Class Analysis (LCA) of five imperfect serological tests to
estimate and derive the probability of M. tuberculosis infection in
elephants.
Results
Sampling in Elephants
About 600 captive Asian elephants were visited for health
assessment in the three southern Indian states of Kerala,
Karnataka and Tamil Nadu. The sampling included healthy
individuals as well as animals with alternative diagnosis such as
chronic arthritis, impaction, and other non-specific symptoms such
as anemia and emaciation. Sera from 179 animals were randomly
selected for this study. Trunk-wash culture for isolation of M.
tuberculosis in select RT positive elephants was carried out with no
elephant testing positive. Post-mortem examination of one RT
positive elephant revealed lung nodules from which M. tuberculosis
was cultured. Ante-mortem serum from this animal was used as
positive control in standardizing the ELISAs and immunoblot
assay.
Evaluation of Humoral Immunoreactivity
One hundred and seventy nine elephants were screened for
differential B-cell responses using RT and recombinant M.
tuberculosis H37Rv antigens in ELISA format. Only selected
reference samples were tested by immunoblot analysis using the
four recombinant antigens and the results were not included in the
LCA model. The immunoblots (Figure 1) were not quantitative in
nature. The RT readout gave either a positive or negative test
result (binary outcome), while the ELISA results were continuous
numerical outcome values (continuous outcome). We dichoto-
mized each continuous test result using a Weibull mixture model
that assumed the elephants were a mixture of two latent groups –
those with the antigen and those without. The cut-off value was
the point of intersection of the two Weibull distributions. The cut-
off values were 0.2 for ESAT-6, 0.337 for CFP10 and 0.22 for
both PE_PGRS11 and PE_PGRS17. Test value greater than each
cut-off was deemed to be a positive test. Of the 179 elephants 33
tested positive in RT, 37 in ESAT-6 ELISA, 41 in CFP10 ELISA,
64 in PE_PGRS11 ELISA and 78 in PE_PGRS17 ELISA
(Figure 1).
Analyzing Diagnostic Test Results using LCA
The LCA assumed in Figure 2 has sixteen latent classes. The
sero-prevalence associated with each latent class is listed in Table 1.
In the absence of any prior information, we chose to use a ‘non-
informative’ prior distribution for the prevalence of M. tuberculosis
infection, allowing for equal weight of all values from 0% to 100%.
Using the posterior distribution, we report that 53.6% (97.5% CI:
44.6% to 62.8%) of the sera samples we tested did not carry any of
the M. tuberculosis antibodies measured by the 5 tests. This estimate
is higher than the 15% sero-prevalence reported by Abraham et al.
(2008, Report submitted to Project Elephant, Ministry of
Environment and Forests, Government of India) using RT in
the same population of captive elephants. We report that the
percentage of M. tuberculosis infected animals testing positive in all
five tests is 15.9% (97.5% CI: 9.8%224.0%). The DSe and DSp of
each test with respect to the target antibody that it is designed to
detect is listed in Table 2. Thus the PE_PGRS11 ELISA had the
highest DSe of 97.6% (97.5% CI: 88.6%299.8%) and DSp of
98.5% (97.5% CI: 93.6%299.9%). Table 2 also lists the DSe and
DSp of each test in detecting the presence of at least one antibody
(Table 1 lists 15 latent classes that are positive for at least one
antibody) as well as the latent antibodies it is not designed to
detect. The main difference between our model and other latent
class models is that we recognize that the different tests are
measuring different latent variables. Thus, for example, we are
able to comment not only on how well RT measures the antigens
it is supposed to detect but also on how well it measures M.
tuberculosis infection that is picked up by other antigens. Finally, the
observed and predicted numbers of elephants for each combina-
tion of test results (Table 3) agree quite well suggesting that the
model fits the data adequately.
Discussion
Latent class analysis is used in a scenario wherein the gold
standard assessment of disease is unavailable and the true infection
status unknown but the results of multiple imperfect tests are
known [32], [33], [34]. This analysis is attractive because it does
not arbitrarily treat one of the tests as a perfect gold-standard with
100% sensitivity and specificity. It allows intuitive construing of
data for input and helps in understanding the uncertainties
associated with the predicted prevalence estimates. A large
number of reports using LCA in veterinary diagnostic tests have
been published [35], [36], [37], [38], [39], [40]. This study uses
LCA to estimate the diagnostic test characteristics of five
serological tests and is the first report of this analysis used to
study TB infection in elephants. This model recognizes that each
Serodiagnosis of Tuberculosis in Asian Elephants
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test is measuring a different target latent variable, which is in turn
associated with the presence of M. tuberculosis infection.
Test validation in the absence of suitable reference samples is
extremely challenging [30], [31]. Culture for clinical isolation of
M. tuberculosis remains the ‘gold standard’ of diagnostics; however a
positive culture result is more likely in animals with advanced stage
of disease. Validation of DSe based on positive culture results may
result in its overestimation under field conditions [38], [40] and
DSe may also vary with severity of disease. Validation of DSp
entails testing of individuals and herds free from infection (a
condition unlikely in TB endemic countries) [41] and may not be
constant across different populations [38], [40]. Variables such as
methods and their operational characteristics, expertise of the
diagnostician, variations in host-pathogen interactions and differ-
ence in true disease prevalence rates may contribute to changes in
performance of tests. Thus, test performance characteristics would
need careful re-evaluation when used in different settings.
In order to decide the cut-off for our new in-house ELISAs, we
had the choice of using either the RT as an imperfect gold
standard or a mixture model. Even though the RT and ELISA
work on the same biological principle, we did not use the former
approach as the RT does not contain any PE_PGRS antigens.
The mixture model for continuous data has been used for
tuberculin skin test induration data among other applications [42].
The LCA is based on the premise that the true disease status is a
common latent (or unobserved) variable associated with several
imperfect tests that measure the same disease [43]. For the LCA,
we delineated 16 latent classes which are the different combina-
tions of the antibodies detected in the study. It would be interesting
to link the latent classes to other disease parameters such as
mortality and clinical signs. The disadvantage of using the LCA
model is that it dichotomizes test results and thus does not use all
the information derived from continuous test results. The choice of
model used is dictated by the type of data and whether the model
assumptions are satisfied. The model we propose is complex and
subject to our interpretation. However, it incorporates results from
five serological assays independent of culture results, estimates the
true seroprevalence within the sampled population and the true
disease status of each animal sampled therein.
Only about 10% of the M. tuberculosis proteome generates
human antibody responses, and this immunoproteome contains
predominantly membrane-associated and secreted proteins [44].
Differences in antibody profiles seen in TB patients need to factor
in host characteristics, bacillary burden and metabolic state and
Figure 1. Differential humoral reactivity of four mycobacterial antigens with Asian elephant sera. For ELISA, elephant sera (1:200) was
allowed to react with ESAT-6 (1 mg/ml) (A), CFP10 (0.5 mg/ml) (D), PE_PGRS11 (0.25 mg/ml) (G) and PE_PGRS17 (0.25 mg/ml) (J). Scatter plots show the
total number of animals testing seronegative and seropositive for each antigen. For immunoblotting, 10 mg of each transferred protein ESAT-6 (C),
CFP10 (F), PE_PGRS11 (I) and PE_PGRS17 (L) was first stained with Ponceau to check for loading control. Next, individual lanes were cut out of the blot
and probed with sera from reference negative and positive animals. B, E, H, K represent immunoblots for one representative negative and positive
animal each. The westerns were not quantitative in nature.
doi:10.1371/journal.pone.0049548.g001
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protein expression by the infecting strain of M. tuberculosis [44],
[45]. Additional complexity is introduced by the multiple clinical
manifestations of disease in humans [46]. This host and pathogen
derived heterogeneity has led to several reviews highlighting the
shortcomings of TB immunodiagnostics [47], [48], [49], [50].
Circulating antibodies have been evaluated as biomarkers for
TB since 1898 [51]. As compared to other members of the PE
family (including PG_PGRS) or mycobacterial antigens,
PE_PGR11 and PE_PGR17 have been shown to elicit stronger
and differential antibody response in humans. Our laboratory
has previously reported that PE_PGR11 and PE_PGR17
elicited antibodies in adult humans with active pulmonary
infection, and in child patients with pulmonary or extrapulmo-
nary TB [27], [28], [52]. Serology studies have demonstrated
that antibodies reactive with a recombinant carboxyterminal
fragment of the PE_PGRS protein from Rv1759c [53] or with
the PGRS domain of Rv3367 [54] are present in human sera of
patients infected with TB. The ESX protein family (for
example, Rv3881c and Rv3784) are preferentially recognized
antibody targets in active TB in humans [44]. The proteins
CFP10 (Rv3784) and ESAT6 (Rv3785) have been evaluated in
a number of veterinary serological assays [21], [22], [55], [56].
This approach is now giving way to whole proteome screening
to identify TB associated proteins and the dynamics of antibody
response they elicit during disease.
The past decade has seen decline of Asian elephant
populations in most range countries with the exception of India
and Sri Lanka [4]. Population depletion reduces the risk of
host-specific infectious diseases except when the pathogen
resides in reservoir hosts or when captivity results in increased
infectious disease transmission [57]. Thus, conservation strate-
gies that increase population density or cross-species contact
such as in zoos, reserves and other captive conditions need
careful evaluation in light of the risks of such infection. Cases of
cross-species TB outbreaks in zoos are well documented [58].
The management of TB in Asian elephants in India remains
inadequate owing to a number of issues including historical and
cultural context of captivity of the species, legality of ownership
(government owned vs. privately- owned) or the costs associated
with the treatment. Albeit the United States Department of
Agriculture has drafted clear guidelines [15] current need
involves a creation of guidelines in regard to regulation of TB
infections in elephants in India. Thus, our current study clearly
proposes periodic verification/testing for TB in captive ele-
phants as well as in-contact personnel.
Factors governing the initiation and expansion of ensuing
immunity to wide ranging infections in elephants are not well
understood. Further, detailed analysis of various effector roles
played by the key components of immune systems such as T cells,
B cells, macrophages or dendritic cells, complement and cytokines
requires extensive investigation. For example, presence of five
subclasses of IgG has been demonstrated in African elephant
(Loxodonta africana) [59], [60]. Further, the genomic organization of
the IgH, Igk, and Igl loci of the African elephant has been
identified [61], [62]. Immunoreactivity analysis demonstrated the
role for complement and antibodies during infections with African
horse sickness [63], [64] Bluetongue [63] and Mycoplasmosis [65].
Interestingly, Alpha Napthyl Acetate Esterase activity was utilized
as a T cell marker to demonstrate T lymphocyte distribution in
peripheral blood [66] and presence of functional CD genes in the
African elephant [67]. Not much tuberculosis disease stage-specific
information is available in Asian elephants and vaccination with
M. bovis BCG has not been evaluated in elephants. Lyaschenko
et al. [21] reported that Multiantigen print immunoassay (MAPIA)
and RT could pick up serum IgG to ESAT-6 and other proteins
up to 3.5 years and 4.0 years respectively prior to culture of M.
Figure 2. Schematic for the multiple latent variable model used in this study. The parameters to be estimated are depicted in oval shapes
and the observed diagnostic test results are represented in rectangular shapes. While RT contains both the ESAT-6 and CFP10 antigens, the ELISAs are
specific for one antigen each.
doi:10.1371/journal.pone.0049548.g002
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tuberculosis from trunk washes. They reported that ESAT6 and
CFP10 were the immunodominant antigens elicited upon
infection of elephants with M. tuberculosis/M. bovis [21], [23].
Significantly, in addition to ESAT-6 and CFP-10, we report high
DSe and DSp for the two PE_PGRS ELISAs based on a latent
class model that recognizes that the different tests are designed to
measure different antigens. The DSe and DSp for the ELISAs we
developed for ESAT6 and CFP10 were comparable to the
commercially available RT test. Importantly, we have attempted
to address immunoreactive potential as well as serodiagnostic
utility of selected antigens of M. tuberculosis H37Rv which would
help in our understanding of the pathophysiological attributes of
TB infection in elephants.
Serology remains an attractive first step in TB diagnosis in
wildlife. It is simple, quick, affordable and does not require
repeated handling of animals. Once elicited, the antibody response
is sustained while the trunk wash culture may yield intermittent
results in elephants. Identifying serological correlates of active TB
in elephants and their use in antitubercular treatment monitoring
[21], [23], [68] could be potentially useful tools in situations where
it is important to keep costs of diagnosis low. We are currently
evaluating cell immunity based assays for TB diagnosis in
elephants. Further studies into TB transmission and surveillance
using accurate, low cost and high throughput assays are also
warranted. Such active disease surveillance in elephant range
countries would help us to study the dynamic relationship between
TB and elephant conservation.
Materials and Methods
Study Population
In the three southern Indian states of Kerala, Karnataka and
Tamil Nadu, there are an estimated 1,000 Asian elephants in
captivity. These animals, mostly caught from the wild but also
born in captivity, are maintained under different ownership and
management regimens. A project for captive elephant health
assessment was undertaken by Asian Nature Conservation
Foundation (Permit No.8-1/2002-PE, Project Elephant, Ministry
of Environment and Forests, Government of India). Apart from
photographic documentation of body condition index, wounds
and injuries with special reference to eyes and feet, routine
haematology, serum biochemistry, urinalysis and dung analysis
were performed for individual elephants. In an attempt to provide
better healthcare to these elephants, the results of each elephant’s
health evaluation was then handed over to the veterinarian in-
charge of the elephant. Following a convenience/opportunity
sampling method, nearly 600 elephants were visited over a period
of one year. A random sample of 179 serum samples collected
from this heath survey was selected for this study.
Table 1. Defining the sixteen latent classes and calculating
their sero-prevalence rates.
Class No. Latent class definition Seroprevalence
Median (95%
CI)* Mean
Class 1 Mtb**+, All antibodies+ 15.9 (9.8, 24.0) 16.2
Class 2 Mtb+, ESAT6+, CFP10+, PE-PGRS11+ 1.3 (0.1, 4.3) 1.5
Class 3 Mtb+, ESAT6+, CFP10+, PE-PGRS17+ 0.4 (0.0, 2.1) 0.6
Class 4 Mtb+, ESAT6+, PE-PGRS11+, PE-
PGRS17+
0.8 (0.0, 4.4) 1.2
Class 5 Mtb+, CFP10+, PE-PGRS11+, PE-
PGRS17+
3.1 (0.2, 10.3) 3.7
Class 6 Mtb+, ESAT6+, CFP10+ 0.8 (0.0, 3.2) 1.0
Class 7 Mtb+, ESAT6+, PE-PGRS11+ 0.6 (0.0, 3.2) 0.9
Class 8 Mtb+, ESAT6+, PE-PGRS17+ 0.5 (0.0, 2.3) 0.7
Class 9 Mtb+, CFP10+, PE-PGRS11+ 0.5 (0.0, 2.6) 0.7
Class 10 Mtb+, CFP10+, PE-PGRS17+ 0.4 (0.0, 2.3) 0.6
Class 11 Mtb+, PE-PGRS11+, PE-PGRS17+ 11.9 (4.2, 18.5) 11.7
Class 12 Mtb+, ESAT6+ 0.7 (0.0, 3.5) 1.0
Class 13 Mtb+, CFP10+ 0.5 (0.0, 2.6) 0.7
Class 14 Mtb+, PE-PGRS11+ 0.7 (0.0, 3.1) 0.9
Class 15 Mtb+, PE-PGRS17+ 4.8 (0.2, 11.8) 5.1
Class 16 Mtb-, All antibodies- 53.6 (44.6, 62.8) 53.6
Latent class definition and the seroprevalence rate for each class thus defined in
the LCA model for studying TB in Asian elephants in southern India. The latent
classes are different combinations of the latent variables (i.e. true presence of
the antibodies) which are present if M. tuberculosis infection is present. *Median
estimate is at the 50% quantile while the 2.5% and 97.5% quantiles define a
95% credible interval (CI). **M. tuberculosis infection.
doi:10.1371/journal.pone.0049548.t001
Table 2. Sensitivity (DSe) and specificity (DSp) of the five
serological tests used in the study.
Test w.r.t.** DSe DSp
Median (95% CI)* Median (95% CI)*
RT At least 1 antibody 48.6 (37.2, 61.0) 99.3 (96.7, 99.9)
ESAT6 44.6 (33.9, 56.4) 95.2 (90.4, 98.2)
CFP10 46.5 (36.0, 58.1) 93.0 (87.8, 96.6)
PE_PGRS11 79.8 (66.7, 90.8) 98.5 (93.6, 99.9)
PE_PGRS17 84.5 (75.2, 91.3) 89.6 (79.4, 98.4)
ESAT6 At least 1 antibody 88.8 (73.5, 97.5) 95.1 (90.5, 98.2)
ESAT6 91.3 (74.8, 99.5) 95.2 (90.4, 98.2)
CFP10 77.0 (61.9, 88.5) 88.9 (83.2, 93.6)
PE_PGRS11 85.0 (71.7, 94.0) 75.9 (68.2, 82.3)
PE_PGRS17 80.3 (66.7, 90.2) 65.7 (57.8, 73.1)
CFP10 At least 1 antibody 88.8 (73.5, 97.5) 95.3 (90.8, 98.2)
ESAT6 75.2 (60.0, 87.1) 91.2 (85.7, 95.2)
CFP10 92.3 (76.9, 99.5) 93.0 (87.8, 96.6)
PE_PGRS11 85.2 (71.5, 94.0) 76.0 (68.5, 82.6)
PE_PGRS17 81.5 (67.9, 91.4) 66.2 (58.3, 73.5)
PE_PGRS11 At least 1 antibody 50.1 (38.2, 62.1) 93.9 (88.8, 97.2)
ESAT6 47.1 (35.8, 58.7) 91.5 (85.9, 95.4)
CFP10 49.1 (38.0, 60.2) 89.4 (83.5, 93.7)
PE_PGRS11 97.6 (88.6, 99.8) 98.5 (93.6, 99.9)
PE_PGRS17 87.1 (77.6, 93.6) 81.4 (73.4, 88.1)
PE_PGRS17 At least 1 antibody 44.4 (32.5, 57.6) 91.6 (85.5, 96.0)
ESAT6 42.2 (30.9, 54.8) 89.6 (83.0, 94.1)
CFP10 44.8 (33.6, 57.1) 87.8 (81.5, 92.7)
PE_PGRS11 82.7 (68.2, 94.3) 91.9 (85.3, 96.5)
PE_PGRS17 97.2 (88.5, 99.9) 89.6 (79.4, 98.7)
The LCA model was used to calculate the DSe and DSp of each test w.r.t. the
antibody it is designed to detect as also presence of at least one antibody. *The
Median estimate refers to the 50% quantile while the 2.5% and 97.5% quantiles
define a 95% credible interval (CI). ** With respect to.
doi:10.1371/journal.pone.0049548.t002
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Materials
Unless otherwise specified all materials used in this study were
purchased from Sigma-Aldrich, St. Louis, USA. Vacutainer
needles (No. 301747), Vacutainer tubes (No. 367820), PANTATM
Supplement, BACTECTM 12B Mycobacteria Culture Vials and
BBLTM Mycobactose Lowenstein-Jensen Medium were procured
from BD (Franklin Lakes, NJ, USA). GammaBind G, Type 2
affinity matrix was bought from GE Healthcare Bio-Sciences
(Uppsala, Sweden), Ni-nitrilotriacetic acid (Ni-NTA) columns from
Qiagen (Valencia, CA, USA), Nunc-Immuno Plates (No 44204)
from NUNC A/S (Roskilde, Denmark) and polyvinylidene
difluoride membranes (PVDF) from Millipore (Bedford, MA,
USA). ECL detection system was bought from Perkin-Elmer (MA,
USA) and 3,39,5,59-tetramethylbenzidine (TMB) and horse radish
peroxidase (HRP)-labeling kit from Bangalore Genei (Bangalore,
Karnataka, India).
Collection of Serum and Screening with RT
Blood was collected by venipuncture of the middle auricular
vein, allowed to clot at room temperature and serum separated
within three hours of collection by centrifugation at 500 g for 10
minutes. Each serum was screened with RT and stored at 270uC
until further testing. The RT (http://www.chembio.com/
animaltest4.html) is a point-of-care lateral flow serological test
licensed by the USDA in 2007. Greenwald et al. [22] reported a
DSp of 95.2% (95% CI, 90.1 to 97.9) and DSe of 100% (95% CI,
84.0%2100%) for the RT.
Trunk-wash Culture for Isolation of M. tuberculosis
The procedure for trunk wash collection as described in the
Guidelines for the Control of Tuberculosis in Elephants, 2008 [15]
was modified [69]. Trunk wash specimens from select RT positive
elephants were tested for M. tuberculosis culture [15]. Briefly, 0.5 ml
of sample supplemented with Erythromysin (32 mg/ml) and
PANTATM Supplement was inoculated into BACTECTM 12B
vials and BBLTM Mycobactose Lowenstein-Jensen Medium and
grown at 37˚C and 10% CO2 for 8 weeks; this was followed by a
niacin-nitrate reduction test for confirming M. tuberculosis. Ante-
mortem serum collected from one elephant, which showed nodules
in the lung tissue during post-mortem examination and from
which M. tuberculosis was cultured on Lowenstein-Jensen medium,
was used as positive control in the serological assays.
Expression and Purification of Recombinant ESAT6,
CFP10, PE-PGRS17 AND PE-PGRS11 Proteins
M. tuberculosis H37Rv antigens EsxA-6 kDa early secretory
antigenic target (ESAT-6) (Rv3875); EsxB-10 kDa culture filtrate
antigen (CFP10) (Rv3874); PE_PGRS17 (Rv0978c) and
PE_PGRS11 (Rv0754) were used as the major antigenic
determinants in this study. Recombinant expression vectors for
Rv3875, Rv3874, Rv0978c and Rv0754 antigens were obtained
from Colorado State University, TB Vaccine Testing and
Research Materials Contract (http://www.cvmbs.colostate.edu/
mip/tb/recombinant.htm) and expressed as described previously
[70]. Briefly, for the expression of His-tagged recombinant
antigens, Escherichia coli BL21(DE3) cells carrying recombinant
plasmids were induced with isopropyl-b-D-thiogalactopyranoside,
and the proteins purified under native conditions (ESAT6 and
CFP10) and denaturing conditions (PE_PGRS17 and
PE_PGRS11) using Ni-NTA columns. In-gel digestions of proteins
for matrix-assisted laser desorption/ionization mass spectrometry
was carried out for identification.
Raising Rabbit Anti-Asian Elephant IgG-horse Radish
Peroxidase (HRP)
Asian elephant IgG was separated from sera [71] and rabbit
anti-Asian elephant IgG raised as per [59] and [60] with
modifications. Briefly, New Zealand white rabbits were injected
subcutaneously at multiple sites with 1 mg of purified Asian
elephant IgG emulsified in equal volume of Freund’s complete
adjuvant followed by a second dose of 500 mg Asian elephant IgG
emulsified in Freund’s incomplete adjuvant. Antibody titres in sera
were determined two weeks post final immunization by ELISA.
The rabbit anti-Asian elephant IgG was coupled to HRP and its
reactivity to elephant IgG was checked. All animal experiments
were approved by the Institutional Ethics Committee for Animal
Table 3. Number of elephants (observed and predicted
according to the latent class model) with each test result.
Binary
Input 2.50% 50% 97.50% Mean Observed
00000 69 82 92 81 84
00001 9 16 26 17 16
00010 0 3 8 3 1
00011 18 24 29 24 26
00100 1 6 13 6 8
00101 0 1 4 1 1
00110 0 0 2 0 1
00111 0 2 6 2 0
01000 0 4 11 4 4
01001 0 1 3 1 1
01010 0 0 2 0 0
01011 0 1 5 2 2
01100 0 0 2 0 0
01101 0 0 1 0 0
01110 0 0 2 0 0
01111 0 2 8 3 2
10000 0 0 4 1 0
10001 0 0 1 0 0
10010 0 0 1 0 0
10011 0 1 3 1 1
10100 0 0 2 0 0
10101 0 0 2 0 0
10110 0 0 2 1 0
10111 1 4 8 4 4
11000 0 0 2 0 0
11001 0 0 2 0 0
11010 0 1 3 1 1
11011 0 3 8 3 2
11100 0 1 2 1 1
11101 0 0 3 1 0
11110 0 2 5 2 2
11111 12 19 25 19 22
Evaluating the fit of the model by comparing the observed and expected
number of elephants with different combinations of tests to see if the
assumptions of the substantive model in Figure 2 were satisfied. 50% refers to
the median estimate while the 2.5% and 97.5% quantiles define a 95% credible
interval (CI).
doi:10.1371/journal.pone.0049548.t003
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Experimentation and Institutional Biosafety Committee, Indian
Institute of Science, Bangalore.
ELISA
Careful checker board titration for optimum protein concen-
tration, elephant sera dilution, rabbit anti-Asian elephant IgG-
HRP was carried out for each individual ELISA. All protein
dilutions were made in 1X PBS (137 mM NaCl; 2.7 mM KCl;
4.3 mM Na2HPO4; 1.47 mM KH2PO4, pH 7.4). 1X PBST (1X
PBS with 0.05% tween-20) was used as wash buffer and 3% BSA
in PBST as blocking buffer. Elephant sera, rabbit anti-Asian
elephant IgG-HRP were each diluted in blocking buffer and
100 ml added per well. ESAT-6 (1 mg/ml), CFP10 (0.5 mg/ml),
PE_PGRS17 and PE_PGRS11 (0.25 mg/ml each) were coated
overnight (o/n) at 4uC into ELISA plates and then washed thrice.
Blocking for 1 hour was followed by addition of elephant sera
(1:200) and incubation o/n at 4uC. After washing, rabbit anti-
Asian elephant IgG-HRP (1:3000) was added and the plate
incubated o/n at 4uC. Tetramethylbenzidine was used as
chromogenic substrate and the absorbance was read at 450 nm
using an ELISA reader (Molecular Devices, Sunnyvale, CA, USA).
Immunoblot Analysis
Ten mg of purified protein was subjected to 12% SDS-PAGE
(Laemmeli) or 10% Tricine SDS-PAGE; transferred to PVDF and
stained with Ponceau to check for loading control. The PVDF was
cut into strips, blocked with 5% nonfat dried milk and each strip
probed with individual elephant sera overnight at 4uC, probed
with rabbit anti-Asian elephant IgG-HRP and the blot visualized
with the ECL detection system.
Statistical Analysis
To adjust for the imperfect nature of the gold-standard
reference, our test validation entailed i) determining an optimal
cut-off for each ELISA using a mixture model for continuous data
ii) using LCA to estimate the DSe and DSp of the five
dichotomous tests. The first step was carried out using the mixdist
library in the R software package [72] assuming that the observed
continuous data on each test arises from a mixture of two Weibull
distributions among the antibody positive and antibody negative
elephants. The point of intersection of the two density functions
was chosen as the optimal cut-off.
The LCA was carried out using the lcmr library in R software
package [43]. This package uses a Bayesian approach to estimate
the parameters of interest. We used non-informative prior
distributions over all parameters so as to let the data dominate
the analysis. The LCA model (Figure 2) assumed that each of the
ELISA tests was measuring a different latent variable (i.e. true
presence of the antibody) which was present if M. tuberculosis
infection was present. Thus, this model adjusts for the correlation
that may arise between tests within the groups of elephants that are
M. tuberculosis infection positive or negative. The RT test was
assumed to measure the presence of both ESAT-6 and CFP10
antibodies while each of the four ELISA was assumed to measure
the presence of the corresponding antibody. The resulting model
had 16 latent classes corresponding to different combinations of
the antibodies (see supplementary document File S1). The fit of the
model was evaluated by comparing the observed and expected
number of elephants with different combinations of tests and a
posterior predictive check for conditional dependence (Table 3).
The predictive values of each test combination were examined to
see if the assumptions of the substantive model in Figure 2 were
satisfied.
Supporting Information
File S1 Algorithm for LCA model.
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